Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00241) | |||||
---|---|---|---|---|---|
Name |
Erythromycin
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
erythromycin; 114-07-8; Erythromycin A; E-Mycin; Erythrocin; Abomacetin; Erythromycinum; Erymax; Eritromicina; Erythromycine; Erythro-Statin; Ilotycin; E-Glades; Ery-Tab; E-Base; Eryacne; Erythromycin base; Torlamicina; Erycette; Robimycin; Bristamycin; Erypar; erythro; Erythroguent; Eritrocina; Erythrogran; Stiemycin; Ermycin; Erycen; Erygel; Pfizer-E; Theramycin Z; Ak-Mycin; Erythromast 36; Erythromycin Lactate; T-Stat; Benzamycin; MFCD00084654; Emycin; Erytab; Inderm; Retcin; UNII-63937KV33D; CHEMBL532; erythromycin-A; Dumotrycin; Mephamycin; CHEBI:42355; Sansac; (-)-ERYTHROMYCIN; Eryc Sprinkles; Erythra-Derm; Akne-Mycin; 63937KV33D; R-P Mycin; Endoeritrin; Eritomicina; Erythroderm; Erytrociclin; Paediathrocin; Pharyngocin; Proterytrin; Acneryne; Acnesol; Aknemycin; Derimer; Deripil; Erisone; Eryacnen; Erydermer; Eryhexal; Erysafe; Iloticina; Latotryd; Lederpax; Mercina; Oftamolets; Pantoderm; Pantodrin; Primacine; Romycin; Stiemicyn; Tiloryth; Tiprocin; E-Solve 2; Emuvin; Erecin; Erymed; Erytop; NCI-C55674; AustriaS; Ery-maxin; Erythro-Teva; Sans-acne; DSSTox_CID_2991; Erimycin-T; Ery-Diolan; Inderm Gel; Del-Mycin; Aknederm Ery Gel; Udima Ery Gel; (-)-Erythromycin, 98%; Eryc 125; UNII-8HPH7ND0LN; DSSTox_RID_76820; DSSTox_GSID_22991; Emu-Ve; 8HPH7ND0LN; Skid Gel E; Akne Cordes Losung; Ilosone (estolate); Ilotycin T.S.; E-Mycin (base); Ery-Tab (base); (-)-Erythromycin, Eur.Ph.; E-Base (base); ERYC (base); C-Solve-2; N-Methylerythromycin A; PCE Dispertab (base); Eryc-125; Eryc-250; Eritromicina [INN-Spanish]; Erythromycine [INN-French]; Erythromycinum [INN-Latin]; Oftalmolosa Cusi Eritromicina; Staticin (TN); Akne-mycin (TN); Erygel (TN); Eryc (TN); T-stat (TN); Pce (TN); SR-05000001618; Sentry AQ mardel maracyn; 9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione; erthromycin; Erythromycines; NSC55929; CCRIS 9078; NSC-55929; HSDB 3074; NCGC00094670-01; Erythromycin [USP:INN:BAN:JAN]; CAS-114-07-8; Prestwick_205; EINECS 204-040-1; Erythromycin C-13; NSC 55929; Spectrum_000115; Spectrum_000659; AI3-50138; Prestwick3_000151; Spectrum2_000759; Spectrum2_001263; Spectrum4_000538; Spectrum5_001596; Erythromycin A, B + C; EC 204-040-1; SCHEMBL2601; BSPBio_000282; BSPBio_002480; Erythromycin standard solution; KBioGR_001175; KBioSS_000555; KBioSS_001139; MLS001066618; BIDD:GT0017; DivK1c_000294; DivK1c_000397; DivK1c_000702; SPECTRUM1500280; SPBio_000778; SPBio_001226; BPBio1_000312; GTPL1456; DTXSID4022991; Erythromycin (JP17/USP/INN); HMS500O16; KBio1_000294; KBio1_000397; KBio1_000702; KBio2_000555; KBio2_001139; KBio2_003123; KBio2_003707; KBio2_005691; KBio2_006275; J01FA01; Erythromycin (mixture of A,B,C); NINDS_000294; NINDS_000397; NINDS_000702; HMS1920M04; HMS2091D05; HMS2095O04; HMS3712O04; Pharmakon1600-01500280; ACT03320; HY-B0220; RKL10096; Tox21_111311; Tox21_111869; Tox21_300515; BDBM50344942; CCG-38992; LMPK04000006; NSC756759; ZINC85534336; Erythromycin, labeled with carbon-13; AKOS015895249; DB00199; MCULE-4566208867; NSC-756759; IDI1_000294; IDI1_000397; IDI1_000702; SMP1_000119; NCGC00179619-01; NCGC00179619-02; NCGC00179619-03; NCGC00254234-01; 82343-12-2; AC-12744; AC-12901; SMR000544946; Erythromycin, potency: >=850 mug per mg; Erythromycin, tested according to Ph.Eur.; SBI-0051368.P003; Erythromycin, N-demethyl-N-(methyl-11C)-; Erythromycin, meets USP testing specifications; C01912; D00140; E-3250; Erythromycin, plant cell culture tested, ~98%; 44496-EP2272846A1; 44496-EP2275422A1; 44496-EP2292608A1; 44496-EP2305644A1; 44496-EP2308866A1; 44496-EP2311814A1; 44496-EP2311828A1; 44496-EP2380568A1; AB00051981_09; AB00051981_10; Erythromycin standard solution, 1 mg/mL in H2O; Erythromycin, Biotechnology Performance Certified; Erythromycin estolate impurity, free erythromycin-; Q213511; SR-01000799155; Erythromycin, Antibiotic for Culture Media Use Only; Erythromycin, BioReagent, suitable for cell culture; SR-01000799155-2; SR-05000001618-1; SR-05000001618-2; BRD-K63550407-001-13-5; BRD-K63550407-028-03-9; Erythromycin (mixture of A,B,C) 100 microg/mL in Acetonitrile; Erythromycin A, British Pharmacopoeia (BP) Reference Standard; Erythromycin A, European Pharmacopoeia (EP) Reference Standard; Erythromycin, United States Pharmacopeia (USP) Reference Standard; Erythromycin, Pharmaceutical Secondary Standard; Certified Reference Material; 215031-94-0
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Pelvic inflammatory disease | ICD-11: GA05 | [1] | ||
PubChem CID | |||||
Formula |
C37H67NO13
|
||||
Canonical SMILES |
CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)O)C)C)O)(C)O
|
||||
InChI |
1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1
|
||||
InChIKey |
ULGZDMOVFRHVEP-RWJQBGPGSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=12560"></iframe>
|
||||
3D MOL is unavailable | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 733.9 | Topological Polar Surface Area | 194 | |
XlogP | 2.7 | Complexity | 1180 | ||
Heavy Atom Count | 51 | Rotatable Bond Count | 7 | ||
Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 14 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Erythromycin 250 mg tablet | Click to Show/Hide the Full List of Formulation(s): 14 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; D&c red no. 30; Sodium citrate; Magnesium stearate; Sorbic acid; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Povidone; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromelloses; Polyethylene glycol
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Physicians Total Care; Rebel Distributors | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
D&C red no. 30 | DIG Info | Heat shock factor 1 (EC50 = 9054 nM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; D&c red no. 30; Sodium citrate; Magnesium stearate; Sorbic acid; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Silicon dioxide; Aluminum oxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromellose phthalate (24% phthalate, 55 cst); Hypromelloses; Polyethylene glycols; Povidones
|
|||||
Dosage Form | Oral Tablet | |||||
Company | AbbVie; Arbor Pharmaceuticals; Avera McKennan Hospital; PD-Rx Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
D&C red no. 30 | DIG Info | Heat shock factor 1 (EC50 = 9054 nM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; D&c red no. 30; Sodium citrate; Magnesium stearate; Sorbic acid; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Silicon dioxide; Aluminum oxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols; Povidones
|
|||||
Dosage Form | Oral Tablet | |||||
Company | A-S Medication Solutions | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
D&C red no. 30 | DIG Info | Heat shock factor 1 (EC50 = 9054 nM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; D&c red no. 30; Sodium citrate; Magnesium stearate; Sorbic acid; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Silicon dioxide; Aluminum oxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols; Povidones
|
|||||
Dosage Form | Oral Tablet | |||||
Company | RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
D&C red no. 30 | DIG Info | Heat shock factor 1 (EC50 = 9054 nM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; D&c red no. 30; Sodium citrate; Magnesium stearate; Sorbic acid; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Aluminum oxide; Cellulose, microcrystalline; Colloidal silicon dioxide; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols; Povidones
|
|||||
Dosage Form | Oral Tablet | |||||
Company | RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
D&C red no. 30 | DIG Info | Heat shock factor 1 (EC50 = 9054 nM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; D&c red no. 30; Sodium citrate, unspecified form; Magnesium stearate; Sorbic acid; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Croscarmellose sodium; Silicon dioxide; Aluminum oxide; Crospovidone (15 mpa.s at 5%); Hydroxypropyl cellulose (1200000 mw); Hypromellose phthalate (24% phthalate, 55 cst); Hypromellose, unspecified; Microcrystalline cellulose; Polyethylene glycol, unspecified; Povidone, unspecified
|
|||||
Dosage Form | Oral Tablet | |||||
Company | A-S Medication Solutions; Carilion Materials Management | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
D&C red no. 30 | DIG Info | Heat shock factor 1 (EC50 = 9054 nM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Sodium citrate; Magnesium stearate; Ammonia; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Silicon dioxide; Cellulose, microcrystalline; Diacetylated monoglycerides; Hydroxypropyl cellulose (type h); Hypromellose phthalate (24% phthalate, 55 cst); Hypromelloses; Povidones
|
|||||
Dosage Form | Delayed Release Oral Tablet | |||||
Company | A-S Medication Solutions; Carilion Materials Management | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Sodium citrate; Magnesium stearate; Sorbic acid; Propylene glycol; Sodium hydroxide; Titanium dioxide; Croscarmellose sodium; Crospovidone; Povidone; Cellulose, microcrystalline; Colloidal silicon dioxide; Hydroxypropyl cellulose; Hypromelloses; Polyethylene glycol
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Stat Rx USA | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 9 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Sodium citrate, unspecified form; Magnesium stearate; Ammonia; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Diacetylated monoglycerides; Hydroxypropyl cellulose (1200000 mw); Hypromellose phthalate (24% phthalate, 55 cst); Hypromellose, unspecified; Microcrystalline cellulose; Povidone, unspecified
|
|||||
Dosage Form | Delayed Release Oral Tablet | |||||
Company | Arbor Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 10 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Sodium citrate; D&c red no. 7; Sorbic acid; Propylene glycol; Titanium dioxide; Carboxymethylcellulose sodium; Povidone; Polacrilin potassium; Polyethylene glycols; Powdered cellulose; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Kaiser Foundation Hospitals; PD-Rx Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Carboxymethylcellulose sodium | DIG Info | Albendazole monooxygenase (EC50 = 12.6 uM) | [5] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Drug Formulation 11 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Sodium citrate; D&c red no. 7; Sorbic acid; Propylene glycol; Titanium dioxide; Carboxymethylcellulose sodium; Polacrilin potassium; Polyethylene glycols; Povidones; Powdered cellulose; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | A-S Medication Solutions; Arbor Pharmaceuticals; RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Carboxymethylcellulose sodium | DIG Info | Albendazole monooxygenase (EC50 = 12.6 uM) | [5] | |||
Drug Formulation 12 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Sodium citrate, unspecified form; D&c red no. 7; Sorbic acid; Propylene glycol; Titanium dioxide; Carboxymethylcellulose sodium, unspecified form; Polacrilin potassium; Polyethylene glycol, unspecified; Povidone, unspecified; Powdered cellulose; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | A-S Medication Solutions | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Drug Formulation 13 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Sodium citrate; D&c red no. 7; Sorbic acid; Titanium dioxide; Carboxymethylcellulose sodium; Polacrilin potassium; Polyethylene glycols; Povidones; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Blenheim Phamacal | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
Carboxymethylcellulose sodium | DIG Info | Albendazole monooxygenase (EC50 = 12.6 uM) | [5] | |||
Drug Formulation 14 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Sodium citrate; D&c red no. 7; Propylene glycol 1,2-distearate; Sorbic acid; Titanium dioxide; Carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide 100-200 mpa.s at 1%); Polacrilin potassium; Polyethylene glycols; Povidones; Powdered cellulose; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
Erythromycin 500 mg tablet | Click to Show/Hide the Full List of Formulation(s): 10 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; D&c red no. 30; Sodium citrate; Magnesium stearate; Sorbic acid; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Povidone; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromelloses; Polyethylene glycol
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Lake Eire Medical & Surgical Supply DBA Quality Care Products; Physicians Total Care; Rebel Distributors | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
D&C red no. 30 | DIG Info | Heat shock factor 1 (EC50 = 9054 nM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; D&c red no. 30; Sodium citrate; Magnesium stearate; Sorbic acid; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Povidone; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromellose 2208 (100 mpa.s); Hypromelloses; Polyethylene glycol
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Cardinal Health | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
D&C red no. 30 | DIG Info | Heat shock factor 1 (EC50 = 9054 nM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; D&c red no. 30; Sodium citrate; Magnesium stearate; Sorbic acid; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Silicon dioxide; Aluminum oxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromellose phthalate (24% phthalate, 55 cst); Hypromelloses; Polyethylene glycols; Povidones
|
|||||
Dosage Form | Oral Tablet | |||||
Company | AbbVie; Arbor Pharmaceuticals; PD-Rx Pharmaceuticals; RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
D&C red no. 30 | DIG Info | Heat shock factor 1 (EC50 = 9054 nM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; D&c red no. 30; Sodium citrate; Magnesium stearate; Sorbic acid; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Silicon dioxide; Aluminum oxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols; Povidones
|
|||||
Dosage Form | Oral Tablet | |||||
Company | A-S Medication Solutions; Lake Eire Medical & Surgical Supply DBA Quality Care Products | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
D&C red no. 30 | DIG Info | Heat shock factor 1 (EC50 = 9054 nM) | [3] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Sodium citrate; Magnesium stearate; Ammonia; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Silicon dioxide; Cellulose, microcrystalline; Diacetylated monoglycerides; Hydroxypropyl cellulose (type h); Hypromellose phthalate (24% phthalate, 55 cst); Hypromelloses; Povidones
|
|||||
Dosage Form | Delayed Release Oral Tablet | |||||
Company | A-S Medication Solutions; PD-Rx Pharmaceuticals; RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Sodium citrate; Magnesium stearate; Ammonia; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Povidone; Cellulose, microcrystalline; Colloidal silicon dioxide; Hydroxypropyl cellulose; Hypromelloses
|
|||||
Dosage Form | Delayed Release Oral Tablet | |||||
Company | Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Sodium citrate, unspecified form; Magnesium stearate; Ammonia; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Diacetylated monoglycerides; Hydroxypropyl cellulose (1200000 mw); Hypromellose phthalate (24% phthalate, 55 cst); Hypromellose, unspecified; Microcrystalline cellulose; Povidone, unspecified
|
|||||
Dosage Form | Delayed Release Oral Tablet | |||||
Company | Arbor Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Vanillin; Citric acid monohydrate; Propylene glycol; Talc; Titanium dioxide; Crospovidone; Silicon dioxide; Cellulose, microcrystalline; Polyethylene glycols; Povidones; Powdered cellulose
|
|||||
Dosage Form | Delayed Release Oral Tablet | |||||
Company | Arbor Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [7] | |||
Vanillin | DIG Info | Aldehyde dehydrogenase 5A1 (IC50 = 15600 nM) | [9] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 9 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Vanillin; Sorbitan monooleate; Magnesium hydroxide; Propylene glycol; Titanium dioxide; Fd&c red no. 3; Povidone; Polacrilin potassium; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Vanillin | DIG Info | Aldehyde dehydrogenase 5A1 (IC50 = 15600 nM) | [9] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [7] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Drug Formulation 10 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Vanillin; Sorbitan monooleate; Magnesium hydroxide; Propylene glycol; Titanium dioxide; Fd&c red no. 3; Polacrilin potassium; Povidones; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Blenheim Phamacal | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Vanillin | DIG Info | Aldehyde dehydrogenase 5A1 (IC50 = 15600 nM) | [9] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [7] | |||
Erythromycin 333 mg tablet | Click to Show/Hide the Full List of Formulation(s): 8 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Sodium citrate; Magnesium stearate; Ammonia; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Hypromellose; Povidone; Silicon dioxide; Caprylic/capric mono/diglycerides; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromellose 2208 (15000 cps)
|
|||||
Dosage Form | Delayed Release Oral Tablet | |||||
Company | Kaiser Foundation Hospitals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Hypromellose | DIG Info | Cytochrome P450 3A5 (IC50 = 19.4 uM) | [5] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Sodium citrate; Magnesium stearate; Ammonia; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Povidone; Silicon dioxide; Caprylic/capric mono/diglycerides; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromellose 2208 (15000 mpa.s); Hypromelloses
|
|||||
Dosage Form | Delayed Release Oral Tablet | |||||
Company | RemedyRepack | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Sodium citrate; Magnesium stearate; Ammonia; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Povidone; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromellose phthalate (24% phthalate, 55 cst); Hypromelloses
|
|||||
Dosage Form | Delayed Release Oral Tablet | |||||
Company | Rebel Distributors | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Sodium citrate; Magnesium stearate; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Povidone; Silicon dioxide; Cellulose, microcrystalline; Diacetylated monoglycerides; Hydroxypropyl cellulose; Hypromellose phthalate (24% phthalate, 55 cst); Hypromelloses
|
|||||
Dosage Form | Delayed Release Oral Tablet | |||||
Company | Stat Rx USA | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 5 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Sodium citrate; Magnesium stearate; Ammonia; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Silicon dioxide; Cellulose, microcrystalline; Diacetylated monoglycerides; Hydroxypropyl cellulose (type h); Hypromellose phthalate (24% phthalate, 55 cst); Hypromelloses; Povidones
|
|||||
Dosage Form | Delayed Release Oral Tablet | |||||
Company | A-S Medication Solutions; Carilion Materials Management; PD-Rx Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 6 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Sodium citrate; Magnesium stearate; Ammonia; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Povidone; Cellulose, microcrystalline; Colloidal silicon dioxide; Hydroxypropyl cellulose; Hypromelloses
|
|||||
Dosage Form | Delayed Release Oral Tablet | |||||
Company | Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
Crospovidone | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 7 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Vanillin; Lactose; D&c red no. 30; Magnesium stearate; Citric acid monohydrate; Propylene glycol; Silicon dioxide; Cellulose, microcrystalline; Povidones; Powdered cellulose; Sodium starch glycolate type a corn
|
|||||
Dosage Form | Delayed Release Oral Tablet | |||||
Company | Arbor Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [7] | |||
D&C red no. 30 | DIG Info | Heat shock factor 1 (EC50 = 9054 nM) | [3] | |||
Vanillin | DIG Info | Aldehyde dehydrogenase 5A1 (IC50 = 15600 nM) | [9] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 8 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Sorbitan monooleate; Sodium citrate, unspecified form; Magnesium stearate; Ammonia; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Diacetylated monoglycerides; Hydroxypropyl cellulose (1200000 mw); Hypromellose phthalate (24% phthalate, 55 cst); Hypromellose, unspecified; Microcrystalline cellulose; Povidone, unspecified
|
|||||
Dosage Form | Delayed Release Oral Tablet | |||||
Company | A-S Medication Solutions; Arbor Pharmaceuticals; PD-Rx Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Carmellose sodium | DIG Info | Albendazole monooxygenase (Protein expression upregulation) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Erythromycin 400 mg tablet | Click to Show/Hide the Full List of Formulation(s): 3 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c red no. 30; D&c yellow no. 10; Fd&c red no. 40; Sodium citrate, unspecified form; Magnesium stearate; Sorbic acid; Propylene glycol; Sucrose; Titanium dioxide; Polacrilin potassium; Polyethylene glycol, unspecified; Powdered cellulose; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Arbor Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [7] | |||
D&C red no. 30 | DIG Info | Heat shock factor 1 (EC50 = 9054 nM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [7] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [8] | |||
Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [4] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Citric acid; Sodium citrate; Magnesium aluminum silicate; Sucrose; Carboxymethylcellulose sodium; Fd&c red no. 3
|
|||||
Dosage Form | Oral Tablet | |||||
Company | PD-Rx Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
Kyselina citronova | DIG Info | Perilipin-1 (IC50 = 3708 nM) | [3] | |||
Carboxymethylcellulose sodium | DIG Info | Albendazole monooxygenase (EC50 = 12.6 uM) | [5] | |||
FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [7] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Fd&c red no. 40; Sodium citrate; Magnesium stearate; Sucrose; Polacrilin potassium; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Physicians Total Care | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sodium citrate anhydrous | DIG Info | Carbonic anhydrase IV (Ki = 99 nM) | [2] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [7] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [8] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Erythromycin 250 mg capsule | Click to Show/Hide the Full List of Formulation(s): 4 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c red no. 30; D&c yellow no. 10; Fd&c blue no. 1; Magnesium stearate; Citric acid monohydrate; Titanium dioxide; Fd&c red no. 3; Povidone; Gelatin; Powdered cellulose
|
|||||
Dosage Form | Delayed Release Oral Capsule | |||||
Company | Kaiser Foundation Hospitals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [8] | |||
D&C red no. 30 | DIG Info | Heat shock factor 1 (EC50 = 9054 nM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [7] | |||
FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [7] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c red no. 30; D&c yellow no. 10; Fd&c blue no. 1; Magnesium stearate; Titanium dioxide; Fd&c red no. 3; Povidone; Gelatin
|
|||||
Dosage Form | Delayed Release Oral Capsule | |||||
Company | Stat Rx USA | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [8] | |||
D&C red no. 30 | DIG Info | Heat shock factor 1 (EC50 = 9054 nM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [7] | |||
FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [7] | |||
Povidone | DIG Info | Cholesterol 25-hydroxylase (IC50 = 78.3 uM) | [5] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c red no. 30; D&c yellow no. 10; Fd&c blue no. 1; Magnesium stearate; Citric acid monohydrate; Titanium dioxide; Fd&c red no. 3; Gelatin; Povidones; Powdered cellulose
|
|||||
Dosage Form | Delayed Release Oral Capsule | |||||
Company | A-S Medication Solutions; Arbor Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [8] | |||
D&C red no. 30 | DIG Info | Heat shock factor 1 (EC50 = 9054 nM) | [3] | |||
Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [7] | |||
FD&C red no. 3 | DIG Info | Phosphodiesterase 3A (IC50 = 0.092 uM) | [7] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Lactose, unspecified form; Fd&c yellow no. 6; Titanium dioxide; Gelatin, unspecified; Povidone, unspecified
|
|||||
Dosage Form | Delayed Release Oral Capsule | |||||
Company | Mayne Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [8] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.